RPG Aventis deal buoys Ranbaxy Labs

DALAL STREET SPIKES

Ranbaxy Laboratories hit a high of Rs 1,082 before closing at Rs 1080.85, up by 0.77 per cent.

More than 2.07 lakh shares were traded on the BSE. The counter saw its price rise on the bourses on good buying interest after the company announced the acquisition of French pharma firm RPG Aventis SA over the weekend.